Clinical Trial Details

Overview

Research Study Summary

A fifteen month, prospective, randomized, active-controlled, open-label, flexible dose study of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to treatment failure in adults with schizophrenia who have been recently released from jail.

Purpose

This study will compare the effects (both good and bad) of paliperidone palmitate to those of several FDA approved oral antipsychotic medications used to treat schizophrenia.

The purpose of this study is to help understand if paliperidone palmitate or oral antipsychotic medication is better at preventing a worsening of your symptoms of schizophrenia which could cause an unfavorable outcome.

Please contact Alexian Brothers for more information on participation.

To Learn more

CW ID: 176869
Date Last Changed: July 22, 2013

Clinical Trial Snapshot

Phase
4
Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Duration
15 Months
Facility Type
N/A

Contact

Alexian Brothers Hospital Network
1786 Moon Lake Boulevard, Suite 200
Hoffman Estates, IL 60169
Phone: 847-230-3599

View Map

Research Center Information:

Alexian Brothers Hospital Network

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.